Ethanol-ecstasy (MDMA) interactions in rats: Preserved attenuation of hyperthermia and potentiation of hyperactivity by ethanol despite prior ethanol treatment

被引:18
作者
Ben Hamida, Sami
Bach, Sonia
Plute, Erin
Jones, Byron C.
Kelche, Christian
Cassel, Jean-Christophe
机构
[1] Univ Strasbourg, CNRS, Inst Federerat Rech 37, GDR 1905,LN2C FRE 2855, F-67000 Strasbourg, France
[2] Penn State Univ, University Pk, PA 16802 USA
关键词
(+/-)-3,4-methylenedioxymethamphetamine; ecstasy; ethanol; locomotor activity; rats; temperature; tolerance;
D O I
10.1016/j.pbb.2006.04.023
中图分类号
B84 [心理学]; C [社会科学总论]; Q98 [人类学];
学科分类号
03 ; 0303 ; 030303 ; 04 ; 0402 ;
摘要
yRecreational use of ecstasy, or (+/-)-3,4-methylenedioxymethamphetamine (MDMA), is often associated with other drugs, among which ethanol is one of the most common. Little is known, however, about the interaction between these two drugs. Using a daily ethanol and/or MDMA administration regimen, we recently showed that ethanol potentiated the hyperactivity (in the home cage), but attenuated the hyperthermia induced by MDMA. The prevention of hyperthermia occurred only on the first of four daily ethanol-MDMA treatments, indicating possible tolerance to ethanol. In order to test the tolerance hypothesis, we treated Long-Evans adult male rats with ethanol on 4 consecutive days prior to their first treatment with MDMA-ethanol. Our results first confirmed that ethanol (1.5 g/kg, i.p.) potentiates the psychomotor effects of MDMA (10 mg/kg, i.p.), while attenuating its pyretic effects (6.6 mg/kg, i.p.). The results also showed that both the potentiation of locomotor activity and the attenuation of hyperthermia by ethanol are not at all altered by prior ethanol treatment. This indicates that tolerance to ethanol per se does not account for what appears to be tolerance to the ethanol-MDMA combination, thus indicating that ethanol-MDMA combination likely has unique pharmacological effects. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:162 / 168
页数:7
相关论文
共 34 条
[1]   ETHANOL STIMULATES [H-3] 5-HT HIGH-AFFINITY UPTAKE BY RAT FOREBRAIN SYNAPTOSOMES - ROLE OF 5-HT RECEPTORS AND VOLTAGE CHANNEL BLOCKERS [J].
ALEXI, T ;
AZMITIA, EC .
BRAIN RESEARCH, 1991, 544 (02) :243-247
[2]  
[Anonymous], 1971, Statistical Principles in Experimental Design
[3]   Ethanol, 3,4-methylenedioxymethamphetamine (ecstasy) and their combination: Long-term behavioral, neurochemical and neuropharmacological effects in the rat [J].
Cassel, JC ;
Riegert, C ;
Rutz, S ;
Koenig, J ;
Rothmaier, K ;
Cosquer, B ;
Lazarus, C ;
Birthelmer, A ;
Jeltsch, H ;
Jones, BC ;
Jackisch, R .
NEUROPSYCHOPHARMACOLOGY, 2005, 30 (10) :1870-1882
[4]   Locomotor and pyretic effects of MDMA-ethanol associations in rats [J].
Cassel, JC ;
Jeltsch, H ;
Koenig, J ;
Jones, BC .
ALCOHOL, 2004, 34 (2-3) :285-289
[5]   INFLUENCE OF AGE ON THE DEVELOPMENT OF RAPID TOLERANCE TO ETHANOL [J].
CHAN, AWK ;
YORK, JL .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1994, 47 (03) :567-573
[6]   Studies on the neuroprotective effect at pentobarbitone on MDMA-induced neurodegeneration [J].
Colado, MI ;
Esteban, B ;
O'Shea, E ;
Granados, R ;
Green, AR .
PSYCHOPHARMACOLOGY, 1999, 142 (04) :421-425
[7]   The pre-clinical behavioural pharmacology of 3,4-methylenedioxymethamphetamine (MDMA) [J].
Cole, JC ;
Sumnall, HR .
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS, 2003, 27 (03) :199-217
[8]   Neurotoxicity of MDMA (ecstasy):: the limitations of scaling from animals to humans [J].
de la Torre, R ;
Farré, M .
TRENDS IN PHARMACOLOGICAL SCIENCES, 2004, 25 (10) :505-508
[9]   Ecstasy: Are animal data consistent between species and can they transtate to humans? [J].
Easton, N ;
Marsden, CA .
JOURNAL OF PSYCHOPHARMACOLOGY, 2006, 20 (02) :194-210
[10]  
FARFEL GM, 1995, J PHARMACOL EXP THER, V272, P860